Text Size
Increase text size
Increase text size

State Board of Pharmacy

Chris M. Gassen, Program Director

Consumer Protection is Our Mission.

The Colorado State Board of Pharmacy (“Board”) regulates pharmacists, pharmacy interns, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses.  The Board consists of five pharmacist members and two public members.  The Board upholds DORA’s mission of consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against those who violate the Pharmacists, Pharmacy Businesses and Pharmaceuticals Act and the Board’s Rules.  The Board works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Counsel.


Pursuant to House Bill 14-1283 (now CRS 12-42.5-403), all Colorado licensed prescribing practitioners who possess an individual DEA registration and all Colorado licensed pharmacists are required to register an individual user account with Colorado's Prescription Drug Monitoring Program (PDMP).  To this end, the Director of the Division of Professions and Occupations has assigned the following due dates for each corresponding profession for this purpose.

  • Pharmacists and DEA-registered Advanced Practice Nurses:  September 30, 2014
  • DEA-registered Dentists, Veterinarians, Optometrists and Podiatrists:  October 31, 2014
  • DEA-registered Medical Board licensees:  November 30, 2014

While all pharmacists and DEA-registered prescribing practitioners may and are certainly encouraged to register a user account with the PDMP at anytime between now and before September 30th, these are the respective due dates for each profession.

To begin this process, please utilize the following link for more information about the PDMP and to begin creating a PDMP account. 

While account creation normally takes less than 5 minutes, should you have questions regarding how to register a PDMP account, please contact the PDMP Help Desk at 1-855-263-6403.

PDMP Task Force Letter from Barbara J. Kelley to The Colorado Consortium to Reduce Prescription Drug Abuse


New! Healthcare Professions Profile (HPPP) Requirement

  • Creating and maintaining a Healthcare Professions Profile is now a requirement (SB 13-026).
  • Healthcare Professions Profiles must be updated within 30 days of a change or reportable event.
  • Click here to create/update your Healthcare Professions Profile.
  • Click here for more information on the Healthcare Professions Profiling Program.


Notice of Rule Making Hearing and Proposed Amendments to Pharmacy Board Rules


Colorado State Board of Pharmacy Prescription Drug Monitoring Program Presentatiion

Wednesday July 23, 2014 at 11am to 12:00pm MST

This presentation is intended for the individual or individuals that will be creating an account and submitting controlled substance prescription dispensing data to the CO PDMP on behalf of Colorado registered pharmacies. In detail it will cover what actions are required by the pharmacy and why as well as other important information. We strongly encourage you to register and look forward to your questions. 

Please register at:

Timeline for Quad-Regulator Opioid Policy

To provide guidance to prescribers and dispensers of opioids, the Quad-Regulator Boards at DORA are collaborating to draft a joint policy as one part of a statewide solution to reduce prescription drug abuse and misuse.  The Quad-Regulator Boards include the Colorado Medical Board, the Colorado State Board of Nursing, the Colorado Board of Pharmacy, and the Colorado State Board of Dental Examiners, facilitated by the Nurse-Physician Advisory Task Force for Colorado Healthcare (NPATCH).  The development of a joint policy by multiple regulatory boards is a first, so the Quad-Regulators are committed to an open process and timeline that allows for full consideration of stakeholder views.To view the policy that will be circulated for Board review and adoption, please click here. Comments and questions may be referred to Cory Everett at cory.everett@state.co.us.

Summer 2013

Separately, Quad-Boards developed policies and/or principles for prescribing and dispensing opioids at Board meetings and stakeholder meetings.

September 2013

Quad-Regulator Conference: Quad Boards met jointly to consider separate policies plus policies from other jurisdictions.

Oct-Dec 2013

Quad-Board Presidents (or their delegates) worked together to merge the four separate policies and practices from other jurisdictions and created first draft of Joint Policy.

January 2014

Legal and science review of draft policy.

February 2014

Draft policy dated 2/20.  Medical Board meetings 2/20 and 2/25.

March 2014

Revised draft dated 3/3.  Pharmacy Board meeting 3/20.  Quad-Stakeholder meeting 3/24.

April 2014

Quad-Board Presidents (or their delegates) worked together to incorporate comments.  Revised draft dated 4/3.  Quad-Stakeholder meeting 4/16.  Dental Board meeting 4/16.  Nursing Board meeting 4/22.



May 2014

Quad-Board Presidents (or their delegates) to work together to incorporate comments.  Revised draft anticipated by 5/16.  Medical Board meeting 5/22.  Quad-Stakeholder meeting anticipated week of 5/26.

June 2014

Deadline for comments on revised draft policy 6/6.  NPATCH meeting 6/6.  Quad-Board Presidents (or their delegates) work together to incorporate comments.  Anticipated first Board vote on policy -- Medical 6/19.

July 2014

Anticipated Board votes on policy -- Pharmacy 7/17, Nursing 7/22, and Dental 7/24.



 Changes to Midwives Statute that Affect Pharmacy

Senate Bill 11-088, which was signed into law in 2011, created two authorities for direct-entry midwives giving the registrants the ability to obtain and administer certain medications and intravenous fluids. The licensees can opt to have one or the other of the authorities or both.

Registrants with the medication authority, which is designated as "MWA" on their license card, can obtain and administer only the following drugs:

  1. Vitamin K1 (phylloquinone, phytonadione);
  2. Rho D immune globulin;
  3. Oxytocin (Pitocin);
  4. Methylergonovine (Methergine);
  5. Misoprostol (Cytotec);
  6. Erythromycin Ophthalmic Ointment.

Registrants with the authority to obtain and administer certain intravenous fluids are designated by "MIV" on their license card. These individuals can obtain and administer only the following intravenous fluids:

  1. 0.9% sodium chloride in sterile water; and
  2. Lactated Ringer's solution (LR).

Please be aware that a direct-entry midwife may have one, both, or none of these authorities. Please verify the midwife's license care prior to distributing any of the above-listed drugs to ensure the individual has the proper authority. This information is also available here.

For Your Information (FYI)....

Registration bulletins for NAPLEX and MPJE can now be downloaded from the National Association of Boards of Pharmacy (NABP) website,and registration forms can be requested online!

The State of Colorado does not register/certify or license Pharmacy Technicians. For information regarding Pharmacy Technician Certification, please visit the Pharmacy Technician Certification Board online.


We Changed Our Name!

The Division is now called the Division of Professions and Occupations, effective August 8, 2012. To help our consumers and licensees more readily locate and utilize our services, the legislature passed House Bill 12-1055 during the 2012 legislative session. Please note, the Division of Professions and Occupations will still be housed within the Department of Regulatory Agencies (DORA). Services the Division currently offers will remain the same.

Legislation passed during the Legislative Session impacts the Division of Professions and Occupations. Please review the program's Laws, Rules and Policies web page to learn of any changes due to legislation.

Adobe Acrobat Reader is required in order to view and print many of these materials. If you do not have Adobe Acrobat Reader, download the latest free version directly from the Adobe website, or convert a document to text.


facebook twitter


1560 Broadway, Suite 1350, Denver, CO 80202 Email
(303) 894-7800 - Phone (303) 894-7693 - Fax